|
|
Volumn 2, Issue 3, 2002, Pages 287-290
|
|
Musculoskeletal diseases: Novel targets for therapeutic intervention
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANALGESIC AGENT;
ANTIINFLAMMATORY AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CHOLINE ACETYLTRANSFERASE;
CORTICOSTEROID;
ESTROGEN;
ETANERCEPT;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARATHYROID HORMONE[1-34];
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
AMYOTROPHIC LATERAL SCLEROSIS;
CHRONIC PAIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG SYNTHESIS;
DRUG TARGETING;
EDITORIAL;
GENE MUTATION;
GUILLAIN BARRE SYNDROME;
HUMAN;
MUSCULOSKELETAL DISEASE;
MYASTHENIA;
MYASTHENIA GRAVIS;
NEUROMUSCULAR DISEASE;
OSTEOARTHRITIS;
OSTEOPOROSIS;
PERIPHERAL NEUROPATHY;
PLASMAPHERESIS;
POSTMENOPAUSE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
|
|
EID: 0036605464
PISSN: 14714892
EISSN: None
Source Type: Journal
DOI: 10.1016/S1471-4892(02)00167-4 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
